Larisa Cervenakova

Title: Larisa Cervenakova: Innovator in Prion Research

Introduction

Larisa Cervenakova is a prominent inventor based in Rockville, MD (US). She has made significant contributions to the field of prion research, holding a total of 4 patents. Her work focuses on developing ligands and methods for detecting and treating prion-associated pathologies.

Latest Patents

Cervenakova's latest patents include innovative ligands that bind to prion proteins. These ligands are designed for detecting or removing prion proteins from various samples, including biological fluids and environmental samples. They can bind to multiple forms of prion proteins, such as cellular prion protein (PrPc), infectious prion protein (PrPsc), and recombinant prion protein (PrPr). Additionally, her patents provide methods for treating or slowing the development of prion-associated pathologies in subjects. Another notable patent involves the use of receptor associated protein (RAP) and its derivatives for the prevention and treatment of prion diseases, regardless of whether the disease is acquired through infection or genetic mutation.

Career Highlights

Throughout her career, Cervenakova has worked with esteemed institutions, including North Carolina State University and Pathogen Removal and Diagnostic Technologies Inc. Her research has significantly advanced the understanding of prion diseases and their treatment.

Collaborations

Cervenakova has collaborated with notable colleagues, including David John Hammond and Julia Tait Lathrop. These partnerships have further enriched her research and contributions to the field.

Conclusion

Larisa Cervenakova's innovative work in prion research has led to valuable patents and advancements in the detection and treatment of prion diseases. Her contributions continue to impact the scientific community and improve understanding of these complex conditions.